with a mean increase of 8 points) and tirzepatide (SUMMIT), appears to be greater than what has been reported for other HFpEF trials investigating the benefits of angiotensin receptorneprilysin inhibitor (Paragon-HF), sodiumglucose cotransporter 2 inhibitors (EMPEROR-Preserved, DELIVER) and spironolactone (TOPCAT)
Healthy fats may support GLP-1 response, though evidence is mixed and context-dependent
BrooksLViardotATsakmakiAStolarczykEHowardJKCaniPDet al
CrossRef Hendershot CS, Bremmer MP, Paladino MB, et al
[DOI] [PubMed] Grattagliano I, Russmann S, Diogo C, Bonfrate L, Oliveira PJ, Wang DQ, et al
Iontophoresis: Uses a mild electrical current to push charged molecules through the skin